secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001193125-21-237704
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q4 FY2021 revenue up 14% to $876.1M, dividend increased 8% to $0.42
--------------------------------------------------------------------------

- Q4 revenue $876.1M (+14% YoY); non-GAAP operating profit up 7%; diluted non-GAAP EPS $1.35.
- Full-year FY2021 revenue $3.2B (+8% YoY); non-GAAP operating profit up 12%; non-GAAP EPS $5.33 (+12%).
- Quarterly dividend raised 8% to $0.42/share; payable Sep 23, record Aug 19.
- Company cites ongoing recovery in sleep apnea patient flow and tailwind from competitor quality issue.
- GAAP net income down 24% for FY due to prior-year gain; non-GAAP net income up 13%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312521237704/0001193125-21-237704-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312521237704/d189129d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-237704

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer